oncology therapy

1 articles
BenzingaBenzinga··Schall Law Firm

Nuvation Bio Stock Plummets 25% as Fraud Probe Launches Over IBTROZI Disclosure

Schall Law Firm investigates $NUVB for potential securities violations after revealing 75% treatment discontinuations in oncology therapy, triggering sharp stock decline.
NUVBstock declinemisleading statements